期刊文献+

3β-乙酰氧基-15β,16β-亚甲基雄甾-5-烯-17-酮的合成 被引量:2

Syntheses of 3β-acetoxy-15β,16β-methyleneandrosta-5- en-17-one
下载PDF
导出
摘要 在二甲亚砜、四氢呋喃或1,4—二氧杂环己烷溶剂中,当温度为12~30℃时,碘化三甲氧硫锤钅翁((CH3)3S+OI-)与氢化钠(NaH)作用1h生成甲基硫氧叶立德,再与3β 乙酰氧基雄甾 5,15 二烯 17 酮(Ⅱ)反应,产物经分离得到环丙化产物3β 乙酰氧基 15β,16β 亚甲基雄甾 5 烯 17 酮;探讨了反应物配比、反应温度、溶剂种类、加料方式对环丙化反应的影响.当反应温度为12℃,n((CH3)3S+OI-)∶n(NaH)∶n(Ⅱ)=1.10∶1.05∶1.00,加料方式为叶立德溶液加入到甾体溶液中,溶剂为二甲亚砜和四氢呋喃(体积比为4∶1)时,用重结晶法分离得产物,产率为80.5%.测试了产物的比位移值Rf、熔点、旋光度,并采用IR,MS和1HNMR等对产物进行了表征. The title compound(Ⅰ) was prepared by nucleophilic addition reaction of 3β-acetoxyandrosta-5,15-dien-17-one (Ⅱ) at 12~30℃. Thus,interaction of trimethylsulfoxonium iodide and sodium hydride gave dimethyl sulfoxonium methylide (Ⅲ) which transferred methylene to (Ⅱ) to form (Ⅰ). The influence of the ratio of reactants, the reaction temperature, the selection of solvents and the addition ways of reactants are discussed. The optimum condition is as follows, n((CH_3)_3S^+OI^- )∶n(NaH)∶n(Ⅱ)=1.10∶(1.05)∶1.00, the temperature is at 12 ℃, the volume fraction of DMSO∶THF is 4∶1, and the addition way is from (Ⅲ) to (Ⅱ). The product is seperated by recrystallization and fair yields (e.g. 80.5%) and stereoselectivity are obtained. The compound (Ⅰ) is characterized by IR, MS and (~1HNMR).
出处 《中南工业大学学报》 CSCD 北大核心 2003年第6期637-640,共4页 Journal of Central South University of Technology(Natural Science)
基金 国家教育部优秀青年教师基金资助项目(1357)
关键词 3β-乙酰氧基雄甾-5 15-二烯-17-酮 甲基硫氧叶立德 3β-乙酰氧基-15β 16β-亚甲基雄甾-5-烯-17-酮 合成 3β-acetoxyandrosta-5,15-dien-17-one dimethyl sulfoxonium methylide 3β-acetoxy-15β,16β-methyleneandrosta-5- en-17-one synthesis
  • 相关文献

参考文献8

  • 1Laurent H, Lipp R. Esperling P, et al. Preparation of oxyiminoprgnane carbolactones for estrogen containing medicines[P]. Ger Offen DE 19651000,1998-06-04.
  • 2Mohr J T. A process for producing drospirenone [P]. WO 98/06738,1998-02-19.
  • 3Junghans C. 3-(3-oxo-4-unsaturated steroid-17α-yl) propionic acid lactones [P]. Ger Offen DE 3306554,1984-08-23.
  • 4Maillos P, Verdan C. Preparation of new substituted 19-norpregnane derivatives as potent prostogens devoid of residual androgenic activity [P]. EP 785211,1997-07-23.
  • 5Plotkin J S. Production of lactones from diols [P]. WO 90/14344,1990-11-29.
  • 6Kamernitskii A V. Galakhova T V. Transformed steroids[J]. Izv Akad Nauk SSSR Ser Khim, 1985.(8):1 893-1 898.
  • 7Corey E J, Michael C. Dimethyloxosulfonium methylide and dimethylsulfonium methylide [J]. J Amer Chem Soc. 1965,87:1 355-1 364.
  • 8Georg A H, Gerhard C, Rudolf W. 15,16-methylene steroids[J]. Chem Ber, 1974,107:128-134.

同被引文献18

  • 1宋发军.甾体药物源植物薯蓣属植物中薯蓣皂甙元的研究及生产状况[J].天然产物研究与开发,2002,14(3):89-93. 被引量:54
  • 2Stevovic L S.An improved approach to B-norsteroids,an one-pot preparation of 3β-acetoxy-5,17-dioxo-5,6-seco-androstan-6-oic acids[J].J Serb Chem Soc,1998,63(2):955-959.
  • 3Brodie A.Synthesis and activity of 17-azolysteroids as androgen synthesis inhibitors[P].US 5994335,1999-10-30.
  • 4Rosenbaum P,Schmidt W,Helmerhorst F M,et al.Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol[J].Eur J Contracept Reprod Health Care,2000,5(1):16-24.
  • 5Mohr J T,Nickisch K.Preparation method for drospirenone[P].Ger DE 19633685,1997-10-09.
  • 6Parsey K S,Pong A.An open-label multiicenter study to evaluate Yasmin,a low-dose combination oral contraceptive containing drospirenone[J].Contraception,2000,61(2):105-111.
  • 7Kelly R W,Sykes P J.Synthesis steroids[J].J Chem Soc ( C ),1968(2):416-421.
  • 8Laurent H,Lipp R.Preparation of oxyiminoprgnane carbolactones for estrogen containing medicines[P].DE 19651000,1998-06-04.
  • 9Mohr J T.A process for producing drospirenone[P].WO 98/06738,1998-02-19.
  • 10LaurentH,LippR.Preparationofoxyiminoprgnanecar bolactonesforestrogencontainingmedicines[].GerOf fenDE.19980604

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部